[1]
Jannot, X. et al. 2025. Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal. European Journal of Case Reports in Internal Medicine. 12, 5 (Apr. 2025). DOI:https://doi.org/10.12890/2025_005355.